Author

Noalani D. Benedict

Colorado State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 1

Frequent Co-Authors

Allison A. BaumaniD· 2 shared Firat KayaiD· 2 shared Gregory T. RobertsoniD· 2 shared Jansy Passiflora SarathyiD· 2 shared Lisa M. Massoudi· 2 shared Matthew D. ZimmermaniD· 2 shared Michelle E. Ramey· 2 shared Anne J. M. Lenaerts· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Allison A. BaumanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Comprehensive preclinical reevaluation of PaBQU and DBQU regimens identifies lesional liability in hard-to-treat forms of tuberculosis

Nicholas D. Walter, Lisa M. Massoudi, Allison Bauman, Noalani D. Benedict, Nathan Peroutka‐Bigus, Michelle E. Ramey, Reem Al Mubarak, Samantha Pauly, Firat Kaya, Linda Chaba, Matthew D. Zimmerman, Debra Flood, David Hermann, Khisimusi Mdluli, David L. Holtzman, , Gregory T. Robertson

This study reevaluates PaBQU and DBQU regimens in mouse models, finding they have lesional liability in complex lesions, which may explain their failure in a human trial.

bioRxiv · Sep 17, 2026 · PreprintMicrobiology

Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis

Allison A. Bauman, Jansy Passiflora Sarathy, Firat Kaya, Lisa M. Massoudi, Michael S. Scherman, Courtney Hastings, Jiuyu Liu, Min Xie, Elizabeth J. Brooks, Michelle E. Ramey, Isabelle L. Jones, Noalani D. Benedict, Madelyn R. Maclaughlin, Jake A. Miller-Dawson, Samanthi L. Waidyarachchi, , Gregory T. Robertson

This study shows that MBX-4888A, a spectinamide, shortens tuberculosis treatment in murine models by improving tissue distribution and working well with rifampin and pyrazinamide.

Antimicrobial Agents and Chemotherapy · Sep 30, 2024Peer-reviewedMicrobiology